CXCL2 and diabetic kidney disease: These findings delineate a “dual track” immunopathogenic model for diabetic nephropathy (DN): On one hand, chemokines such as CXCL2 drive the activation of innate immune components including NK cells; on the other hand, they induce functional dysregulation of CD4+ T cells.